Manufacturer
Gsms
- Products listed
- 9
- Molecules
- 3
- Therapy areas
- 2
Gsms is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 9 of its products across 3 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- GSMS, Incorporated
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Gsms products through licensed channels, with the documents your regulator needs.
Diabetes
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Pioglitazone 15 mg tabletOralGeneric name | Pioglitazone | US FDA | Available on request |
| Pioglitazone 30 mg tabletOralGeneric name | Pioglitazone | US FDA | Available on request |
| Pioglitazone 45 mg tabletOralGeneric name | Pioglitazone | US FDA | Available on request |
Cardiology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Ramipril 10 mg capsuleOralGeneric name | Ramipril | US FDA | Available on request |
| Ramipril 2.5 mg capsuleOralGeneric name | Ramipril | US FDA | Available on request |
| Ramipril 5 mg capsuleOralGeneric name | Ramipril | US FDA | Available on request |
Other products
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Hydrochlorothiazide and Lisinopril 12.5 mg/10 mg tabletOralGeneric name | Hydrochlorothiazide and Lisinopril | US FDA | Available on request |
| Hydrochlorothiazide and Lisinopril 12.5 mg/20 mg tabletOralGeneric name | Hydrochlorothiazide and Lisinopril | US FDA | Available on request |
| Hydrochlorothiazide and Lisinopril 25 mg/20 mg tabletOralGeneric name | Hydrochlorothiazide and Lisinopril | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Gsms
Send a request for any of these products. We confirm the licensed source, documents and lead time.